79–1.58] in Uruguay to 2.29 [1.37–3.83] in China. The pooled AOR for the all-country data was 1.61 [1.46–1.79]. Female participants were less

likely than males to live in a smoke-free home in most LMICs but associations were only significant in India, Bangladesh, Brazil, Poland, Russian Federation, Turkey, Ukraine and Egypt. Participants from urban settings in India, Thailand, China, Philippines, Viet Nam, Brazil and Egypt were significantly more likely to live in a smoke-free home compared with those from the rural settings. In contrast, participants from rural settings were significantly more likely Panobinostat order to live in a smoke-free home in Romania, Russian Federation and Ukraine. The likelihood of living in a smoke-free home significantly increased with increasing education level in India,

Bangladesh, Thailand, Philippines, Ukraine and Egypt. Non-smokers were consistently more likely to live in a smoke-free home than smokers. No association was observed between SLT use and living in a smoke-free home. This study utilized data from the first round of GATS, conducted in 15 LMICs between 2008 and 2011, to examine whether being employed in a smoke-free workplace is associated with living in a smoke-free home. this website We found positive associations in all of the 15 LMICs studied (13 out of 15 being statistically significant) in individual level country-specific analysis. The pooled estimate indicated that participants employed in a smoke-free workplace were 60% more likely to live in a smoke-free home compared with those that worked where smoking occurred. These findings are consistent with those from previous studies conducted in high income settings. Cheng et al. (2011) in a longitudinal study conducted in the USA suggested that living in smoke-free homes

was four to seven times more likely among those employed in a 100% smoke-free workplace (compared with those employed in workplaces where smoking occurred). Another longitudinal study found similar reductions in smoking at home after the introduction of comprehensive Mephenoxalone smoke-free policies in Ireland (85% to 80%; p = 0.002) and the UK (82% to 76%; p = 0.003) (Fong et al., 2006). An evaluation of the smoke-free policy introduced in New Zealand in 2004 suggested that SHS exposure at workplaces decreased from 20% to 8% and the proportion of smoke-free homes increased from 64% to 70% between 2003 and 2006 (Edwards et al., 2008). Article 8 of WHO Framework Convention on Tobacco Control (FCTC) requires parties to adopt and implement measures to reduce exposure to tobacco smoke in indoor workplaces, indoor public places, public transport and other public places (World Health Organization, 2003). However, disparities observed in the implementation and enforcement of Article 8 of FCTC in LMICs (World Health Organization, 2013b) suggest that these benefits are not being fully realized.